Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?

被引:316
|
作者
Cappelletti, Simone [1 ]
Daria, Piacentino [2 ]
Sani, Gabriele [2 ]
Aromatario, Mariarosaria [1 ]
机构
[1] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Sch Med & Psychol, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, I-00161 Rome, Italy
关键词
Abuse; caffeine; coffee; dependence; energy drinks; safety doses; toxicity; ENERGY DRINK CONSUMPTION; ADENOSINE A(2A) RECEPTOR; BLOOD-PRESSURE; COFFEE CONSUMPTION; PARKINSONS-DISEASE; MEMORY IMPAIRMENT; DIETARY CAFFEINE; HEART-DISEASE; SHORT-TERM; RAT MODEL;
D O I
10.2174/1570159X13666141210215655
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Caffeine use is increasing worldwide. The underlying motivations are mainly concentration and memory enhancement and physical performance improvement. Coffee and caffeine-containing products affect the cardiovascular system, with their positive inotropic and chronotropic effects, and the central nervous system, with their locomotor activity stimulation and anxiogenic-like effects. Thus, it is of interest to examine whether these effects could be detrimental for health. Furthermore, caffeine abuse and dependence are becoming more and more common and can lead to caffeine intoxication, which puts individuals at risk for premature and unnatural death. The present review summarizes the main findings concerning caffeine's mechanisms of action (focusing on adenosine antagonism, intracellular calcium mobilization, and phosphodiesterases inhibition), use, abuse, dependence, intoxication, and lethal effects. It also suggests that the concepts of toxic and lethal doses are relative, since doses below the toxic and/or lethal range may play a causal role in intoxication or death. This could be due to caffeine's interaction with other substances or to the individuals' preexisting metabolism alterations or diseases.
引用
收藏
页码:71 / 88
页数:18
相关论文
共 50 条
  • [21] Effects of caffeine and glucose, alone and combined, on cognitive performance
    Adan, Ana
    Maria Serra-Grabulosa, Josep
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (04) : 310 - 317
  • [22] The effect of caffeine on cognitive task performance and motor fatigue
    Hiske van Duinen
    Monicque M. Lorist
    Inge Zijdewind
    [J]. Psychopharmacology, 2005, 180 : 539 - 547
  • [23] The Influence of Caffeine Expectancies on Sport, Exercise, and Cognitive Performance
    Shabir, Akbar
    Hooton, Andy
    Tallis, Jason
    Higgins, Matthew F.
    [J]. NUTRIENTS, 2018, 10 (10)
  • [24] Microneedles: A Valuable Physical Enhancer to Increase Transdermal Drug Delivery
    Juan Escobar-Chavez, Jose
    Bonilla-Martinez, Dalia
    Angelica Villegas-Gonzalez, Martha
    Molina-Trinidad, Eva
    Casas-Alancaster, Norma
    Luisa Revilla-Vazquez, Alma
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (07): : 964 - 977
  • [25] Ergogenic Effect Of Caffeine On The Physical Maximum Performance Of Cyclists
    Tirapegui, Julio
    Leitao, Helcyo A.
    Leal, Francisco L. T.
    Rocha, Francisco C.
    Neto, Emidio M. M.
    Figueiredo, Rodrigo G.
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2008, 40 (05): : S361 - S361
  • [26] Placebo Effect of Caffeine on Physiological Parameters and Physical Performance
    Ortiz-Sanchez, David
    Bravo-Sanchez, Alfredo
    Ramirez-delaCruz, Maria
    Abian, Pablo
    Abian-Vicen, Javier
    [J]. NUTRIENTS, 2024, 16 (10)
  • [27] PSYCHOACTIVE DRUG INTERACTIONS
    GAULTIERI, CT
    POWELL, SF
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1978, 39 (09) : 720 - 729
  • [28] PSYCHOACTIVE DRUG UTILIZATION
    GARDNER, EA
    [J]. JOURNAL OF DRUG ISSUES, 1971, 1 (04) : 295 - 300
  • [29] NICOTINE AS A PSYCHOACTIVE DRUG
    MURRAY, JB
    [J]. JOURNAL OF PSYCHOLOGY, 1991, 125 (01): : 5 - 25
  • [30] Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers
    Ngoundo-Mbongue, TB
    Niezborala, M
    Sulem, P
    Briant-Vincens, D
    Bancarel, Y
    Jansou, P
    Chastan, E
    Montastruc, JL
    Lapeyre-Mestre, M
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (02) : 81 - 89